15 research outputs found
Effect of dietary organic acids and humic substance supplementation on performance, immune response and gut morphology of broiler chickens
This study evaluated the additive effects of a commercial feed supplementation blend (Ava Cid P)—consisting of humic substances, coated sodium butyrate, and a small acidifier portion— on the growth, immune response, and gut health of broiler chickens. A total of 540 female and 540 male broilers were raised from 1–49 d. On the first day, the animals were distributed in a completely randomized 2 × 5 factorial design (2 sexes and 5 treatments) with 7 replications of 15 birds each. The 5 treatments were 1) birds did not receive Ava Cid P (control); 2) birds received 0.91 kg/t of Ava Cid P from 1–21 d (AVA1–21); 3) birds received 0.91 kg/t of Ava Cid P from 1–21 d and 0.45 kg/t from 22–35 d (AVA1–35); 4) birds received 0.91 kg/t of Ava Cid P from 1–21 d and 0.45 kg/t from 22–42 d (AVA1–42); and 5) birds received 0.91 kg/t of Ava Cid P from 1–21 d, 0.45 kg/t from 22–35 d, and 0.23 kg/t from 36–49 d (AVA1–49). ANOVA and Tukey’s tests were applied to compare the means (P < 0.05) between treatments. The Ava Cid P showed no effect on male or female growth performance or goblet cell density. However, the supplement modified gut morphometry, and jejunum villi were 32% higher at 9 and 35 d in the AVA1–35 birds compared with those of the control group. The apparent villus surface and villus height increased by 87% and 46%, respectively, in the AVA1–49 birds compared with the AVA1–21 birds. The expression of mucin 2 (MUC2) and tumor necrosis factor-alpha (TNF-α) were 1.6% and 0.9% lower in the AVA1–21 birds than in the control birds, but no effects were observed for interleukin-1 beta and interleukin-10. The Ava Cid P altered the mRNA expression of MUC2 and TNF-α and some characteristics of intestinal morphometry, but did not change the performance of broilers
Avaliação dos parâmetros ambientais e fisiológicos para frangos de corte linhagem caipira em diferentes fases de criação na Amazônia Ocidental / Evaluation of environmental and physiological parameters for free-range broilers in different productive phases in the Western Amazon
Objetivou-se com este trabalho avaliar a influĂŞncia do ambiente em diferentes perĂodos do dia sobre os parâmetros fisiolĂłgicos de frangos caipira da linhagem Label Rouge em diferentes fases de criação (inicial, crescimento e terminação) na AmazĂ´nia Ocidental. Foram utilizados 300 pintinhos da linhagem Caipira Label Rouge, distribuĂdos em vinte cinco boxes de 12 animais cada. Semanalmente foram coletados dados de temperatura de bulbo seco, temperatura de ponto de orvalho, temperatura de globo negro e umidade relativa no interior do galpĂŁo, em trĂŞs pontos (inĂcio, meio e fim) e em diferentes horários, 09:00, 15:00 e 21:00 horas. A partir da coleta das variáveis climáticas foram calculados os Ăndices de conforto tĂ©rmico: Ăndices de temperatura e umidade e o Ăndice de temperatura de globo e umidade. Os parâmetros fisiolĂłgicos foram avaliados em cada fase de criação (inicial, crescimento e final), nas idades de 21, 42 e 63 dias, considerando as variáveis, temperatura cloacal, temperaturas superficiais (cabeça, pescoço, dorso, asa e pernas) e frequĂŞncia respiratĂłria. Os resultados dos Ăndices bioclimáticos demonstraram que em todas fases de criação os animais se encontravam fora da faixa de conforto tĂ©rmico de temperatura e umidade relativa, sendo os maiores Ăndices (p<0,05) observados no perĂodo da tarde. Para os parâmetros fisiolĂłgicos, foi possĂvel observar que houve incremento (p<0,05) em todas as temperaturas mensuradas, como tambĂ©m, na frequĂŞncia respiratĂłria (p<0,05) no perĂodo da tarde nas fases inicial e crescimento. Sendo assim, conclui-se que as altas temperaturas associadas a alta umidade no perĂodo da tarde aumentaram os Ăndices bioclimáticos e o desconforto dos animais, alterando as temperaturas superficiais e frequĂŞncia respiratĂłria de frangos caipiras Label Rouge criados na AmazĂ´nia Ocidental.Â
Diretriz sobre Diagnóstico e Tratamento da Cardiomiopatia Hipertrófica – 2024
Hypertrophic cardiomyopathy (HCM) is a form of genetically caused heart muscle disease, characterized by the thickening of the ventricular walls. Diagnosis requires detection through imaging methods (Echocardiogram or Cardiac Magnetic Resonance) showing any segment of the left ventricular wall with a thickness > 15 mm, without any other probable cause. Genetic analysis allows the identification of mutations in genes encoding different structures of the sarcomere responsible for the development of HCM in about 60% of cases, enabling screening of family members and genetic counseling, as an important part of patient and family management. Several concepts about HCM have recently been reviewed, including its prevalence of 1 in 250 individuals, hence not a rare but rather underdiagnosed disease. The vast majority of patients are asymptomatic. In symptomatic cases, obstruction of the left ventricular outflow tract (LVOT) is the primary disorder responsible for symptoms, and its presence should be investigated in all cases. In those where resting echocardiogram or Valsalva maneuver does not detect significant intraventricular gradient (> 30 mmHg), they should undergo stress echocardiography to detect LVOT obstruction. Patients with limiting symptoms and severe LVOT obstruction, refractory to beta-blockers and verapamil, should receive septal reduction therapies or use new drugs inhibiting cardiac myosin. Finally, appropriately identified patients at increased risk of sudden death may receive prophylactic measure with implantable cardioverter-defibrillator (ICD) implantation.La miocardiopatĂa hipertrĂłfica (MCH) es una forma de enfermedad cardĂaca de origen genĂ©tico, caracterizada por el engrosamiento de las paredes ventriculares. El diagnĂłstico requiere la detecciĂłn mediante mĂ©todos de imagen (Ecocardiograma o Resonancia MagnĂ©tica CardĂaca) que muestren algĂşn segmento de la pared ventricular izquierda con un grosor > 15 mm, sin otra causa probable. El análisis genĂ©tico permite identificar mutaciones en genes que codifican diferentes estructuras del sarcĂłmero responsables del desarrollo de la MCH en aproximadamente el 60% de los casos, lo que permite el tamizaje de familiares y el asesoramiento genĂ©tico, como parte importante del manejo de pacientes y familiares. Varios conceptos sobre la MCH han sido revisados recientemente, incluida su prevalencia de 1 entre 250 individuos, por lo tanto, no es una enfermedad rara, sino subdiagnosticada. La gran mayorĂa de los pacientes son asintomáticos. En los casos sintomáticos, la obstrucciĂłn del tracto de salida ventricular izquierdo (TSVI) es el trastorno principal responsable de los sĂntomas, y su presencia debe investigarse en todos los casos. En aquellos en los que el ecocardiograma en reposo o la maniobra de Valsalva no detecta un gradiente intraventricular significativo (> 30 mmHg), deben someterse a ecocardiografĂa de esfuerzo para detectar la obstrucciĂłn del TSVI. Los pacientes con sĂntomas limitantes y obstrucciĂłn grave del TSVI, refractarios al uso de betabloqueantes y verapamilo, deben recibir terapias de reducciĂłn septal o usar nuevos medicamentos inhibidores de la miosina cardĂaca. Finalmente, los pacientes adecuadamente identificados con un riesgo aumentado de muerte sĂşbita pueden recibir medidas profilácticas con el implante de un cardioversor-desfibrilador implantable (CDI).A cardiomiopatia hipertrĂłfica (CMH) Ă© uma forma de doença do mĂşsculo cardĂaco de causa genĂ©tica, caracterizada pela hipertrofia das paredes ventriculares. O diagnĂłstico requer detecção por mĂ©todos de imagem (Ecocardiograma ou Ressonância MagnĂ©tica CardĂaca) de qualquer segmento da parede do ventrĂculo esquerdo com espessura > 15 mm, sem outra causa provável. A análise genĂ©tica permite identificar mutações de genes codificantes de diferentes estruturas do sarcĂ´mero responsáveis pelo desenvolvimento da CMH em cerca de 60% dos casos, permitindo o rastreio de familiares e aconselhamento genĂ©tico, como parte importante do manejo dos pacientes e familiares. Vários conceitos sobre a CMH foram recentemente revistos, incluindo sua prevalĂŞncia de 1 em 250 indivĂduos, nĂŁo sendo, portanto, uma doença rara, mas subdiagnosticada. A vasta maioria dos pacientes Ă© assintomática. Naqueles sintomáticos, a obstrução do trato de saĂda do ventrĂculo esquerdo (OTSVE) Ă© o principal distĂşrbio responsável pelos sintomas, devendo-se investigar a sua presença em todos os casos. Naqueles em que o ecocardiograma em repouso ou com Manobra de Valsalva nĂŁo detecta gradiente intraventricular significativo (> 30 mmHg), devem ser submetidos Ă ecocardiografia com esforço fĂsico para detecção da OTSVE. Pacientes com sintomas limitantes e grave OTSVE, refratários ao uso de betabloqueadores e verapamil, devem receber terapias de redução septal ou uso de novas drogas inibidoras da miosina cardĂaca. Por fim, os pacientes adequadamente identificados com risco aumentado de morta sĂşbita podem receber medida profilática com implante de cardiodesfibrilador implantável (CDI)
Pervasive gaps in Amazonian ecological research
Biodiversity loss is one of the main challenges of our time,1,2 and attempts to address it require a clear un derstanding of how ecological communities respond to environmental change across time and space.3,4
While the increasing availability of global databases on ecological communities has advanced our knowledge
of biodiversity sensitivity to environmental changes,5–7 vast areas of the tropics remain understudied.8–11 In
the American tropics, Amazonia stands out as the world’s most diverse rainforest and the primary source of
Neotropical biodiversity,12 but it remains among the least known forests in America and is often underrepre sented in biodiversity databases.13–15 To worsen this situation, human-induced modifications16,17 may elim inate pieces of the Amazon’s biodiversity puzzle before we can use them to understand how ecological com munities are responding. To increase generalization and applicability of biodiversity knowledge,18,19 it is thus
crucial to reduce biases in ecological research, particularly in regions projected to face the most pronounced
environmental changes. We integrate ecological community metadata of 7,694 sampling sites for multiple or ganism groups in a machine learning model framework to map the research probability across the Brazilian
Amazonia, while identifying the region’s vulnerability to environmental change. 15%–18% of the most ne glected areas in ecological research are expected to experience severe climate or land use changes by
2050. This means that unless we take immediate action, we will not be able to establish their current status,
much less monitor how it is changing and what is being lostinfo:eu-repo/semantics/publishedVersio
Pervasive gaps in Amazonian ecological research
Biodiversity loss is one of the main challenges of our time,1,2 and attempts to address it require a clear understanding of how ecological communities respond to environmental change across time and space.3,4 While the increasing availability of global databases on ecological communities has advanced our knowledge of biodiversity sensitivity to environmental changes,5,6,7 vast areas of the tropics remain understudied.8,9,10,11 In the American tropics, Amazonia stands out as the world's most diverse rainforest and the primary source of Neotropical biodiversity,12 but it remains among the least known forests in America and is often underrepresented in biodiversity databases.13,14,15 To worsen this situation, human-induced modifications16,17 may eliminate pieces of the Amazon's biodiversity puzzle before we can use them to understand how ecological communities are responding. To increase generalization and applicability of biodiversity knowledge,18,19 it is thus crucial to reduce biases in ecological research, particularly in regions projected to face the most pronounced environmental changes. We integrate ecological community metadata of 7,694 sampling sites for multiple organism groups in a machine learning model framework to map the research probability across the Brazilian Amazonia, while identifying the region's vulnerability to environmental change. 15%–18% of the most neglected areas in ecological research are expected to experience severe climate or land use changes by 2050. This means that unless we take immediate action, we will not be able to establish their current status, much less monitor how it is changing and what is being lost
High Incubation Temperature and Threonine Dietary Level Improve Ileum Response Against Post-Hatch <i>Salmonella</i> Enteritidis Inoculation in Broiler Chicks
<div><p>This study assessed the effect of both embryonic thermal manipulation and dietary threonine level on the response of broilers inoculated with <i>Salmonella</i> Enteritidis, considering bacterial counts in the cecal contents, intestinal morphology, mucin and heat shock protein 70 gene expression, body weight and weight gain. Thermal manipulation was used from 11 days of incubation until hatch, defining three treatments: standard (37.7°C), continuous high temperature (38.7°C) and continuous low temperature (36.7°C). After hatch, chicks were distributed according to a 3x2+1 factorial arrangement (three temperatures and two threonine levels and one sham-inoculated control). At two days of age, all chicks were inoculated with <i>Salmonella</i> Enteritidis, except for the sham-inoculated control group. There was no interaction between the factors on any analyses. High temperature during incubation was able to reduce colonization by <i>Salmonella</i> Enteritidis in the first days, reducing both <i>Salmonella</i> counts and the number of positive birds. It also increased mucin expression and decreased Hsp70 expression compared with other inoculated groups. High temperature during incubation and high threonine level act independently to reduce the negative effects associated to <i>Salmonella</i> Enteritidis infection on intestinal morphology and performance, with results similar to sham-inoculated birds. The findings open new perspectives for practical strategies towards the pre-harvest <i>Salmonella</i> control in the poultry industry.</p></div
Ileum heat shock protein 70 kDA (Hsp70) mRNA of chicks at 10 days of age (n = 3 per treatment).
<p>Changes in Hsp70 mRNA expression are normalized to β-actin mRNA and expressed relative to the reference gene. Means followed by the same small letter are similar by Tukey’s test. Means followed by the same capital letter are similar to the sham-inoculated treatment (Control) by Dunnet’s test (5%). SE-inoculated, inoculated with <i>Salmonella</i> Enteritidis at 2 days of age; sham-inoculated, inoculated with nutrient broth at 2d. (A) Effect of thermal manipulation during incubation. (B) Effect of post-hatch threonine dietary levels.</p